Heparin Binding Nanostructures to Promote Growth of Blood Vessels
Top Cited Papers
- 3 August 2006
- journal article
- research article
- Published by American Chemical Society (ACS) in Nano Letters
- Vol. 6 (9) , 2086-2090
- https://doi.org/10.1021/nl0613555
Abstract
Controlling new blood vessel formation is of interest in regenerative medicine and cancer treatment. Heparin, a biopolymer that binds to angiogenic growth factors, was used to nucleate the self-assembly of nanostructures from designed peptide amphiphile molecules. This process yields rigid nanofibers that display heparin chains to orient proteins for cell signaling. In vivo, the nanostructures stimulated extensive new blood vessel formation using nanogram amounts of growth-factor proteins that by themselves did not induce any detectable angiogenesis.Keywords
This publication has 29 references indexed in Scilit:
- Synthetic biomaterials as instructive extracellular microenvironments for morphogenesis in tissue engineeringNature Biotechnology, 2005
- Sustained release of vascular endothelial growth factor from calcium-induced alginate hydrogels reinforced by heparin and chitosanTransplantation Proceedings, 2004
- Smart BiomaterialsScience, 2004
- Tissue engineering strategies for in vivo neovascularisationExpert Opinion on Biological Therapy, 2002
- Sustained release of basic fibroblast growth factor and angiogenesis in a novel covalently crosslinked gel of heparin and alginateJournal of Biomedical Materials Research, 2001
- Angiogenesis in cancer and other diseasesNature, 2000
- Clinical applications of angiogenic growth factors and their inhibitorsNature Medicine, 1999
- DNA delivery from polymer matrices for tissue engineeringNature Biotechnology, 1999
- Tissue EngineeringScience, 1993
- Angiogenic FactorsScience, 1987